In the T47D no-special type (invasive ductal carcinoma [IDC]-NST) cell line, overexpression of the most significant ESR1 fusion proteins revealed an estrogen response signature that was subsequently developed into a 24-gene signature as a biomarker for functional fusion activity (27). Here, ESR1 is linked to invasive ductal breast carcinoma.